Detection of Emerging Resistant Clones in Philadelphia-Positive Leukemia Patients Exposed to Tyrosine Kinase Inhibitors. Correlation of cDNA and Gdna Approaches
Ricardo Sánchez(Research Institute Hospital 12 de Octubre), Santiago Barrio, Inmaculada Rapado(Wellcome Sanger Institute), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Laura Rufián(Hospital Universitario 12 De Octubre), Jaime Carrillo(Instituto de Investigaciones Biomédicas Sols-Morreale), Chongwu Wang, Yanira Heredia(Hospital Universitario 12 De Octubre), Esther Onecha(Hospital Universitario 12 De Octubre), Juan Manuel de la Rosa(Hospital Universitario 12 De Octubre), Rosa Ayala(Hospital Universitario 12 De Octubre), Josep‐María Ribera(Universitat Autònoma de Barcelona), José María Sánchez‐Pina(Research Institute Hospital 12 de Octubre), María José Pedraja Linares(Universidad Complutense de Madrid), Gonzalo Carreño Gomez-Tarragona(Hospital Universitario 12 De Octubre)
Cited by 2
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532